Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China · Delayed Price · Currency is CNY 61.72
+0.83 (1.36%)
At close: Jul 22, 2025, 2:57 PM CST
SHE:301033 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | 88.07 | 78.85 | 40.88 | 35.73 | 44.71 | 36.97 | Upgrade |
Depreciation & Amortization | 26.73 | 26.73 | 25.33 | 15.16 | 8.19 | 5.04 | Upgrade |
Other Amortization | 1.18 | 1.18 | 1.22 | 1.35 | 1.46 | 1.39 | Upgrade |
Loss (Gain) From Sale of Assets | -0 | -0 | - | -0.17 | -0.01 | -0.08 | Upgrade |
Asset Writedown & Restructuring Costs | 0.48 | 0.48 | 0.22 | 1.25 | 0.01 | 0.29 | Upgrade |
Loss (Gain) From Sale of Investments | -3.59 | -3.59 | -3.69 | -7.99 | -7.08 | -5.29 | Upgrade |
Provision & Write-off of Bad Debts | 0.1 | 0.1 | 0.04 | 0.03 | -0.05 | 0.05 | Upgrade |
Other Operating Activities | 2.95 | -1.15 | 2.21 | -1.93 | 1.1 | 0.64 | Upgrade |
Change in Accounts Receivable | -4.43 | -4.43 | -7.14 | -6.78 | 2.2 | -3.94 | Upgrade |
Change in Inventory | -8.15 | -8.15 | 3.19 | -8.27 | -4.64 | -1.01 | Upgrade |
Change in Accounts Payable | 16.18 | 16.18 | 43.8 | 16.18 | 17.92 | -2.06 | Upgrade |
Change in Other Net Operating Assets | 13.18 | 13.18 | 5.44 | -0.2 | - | - | Upgrade |
Operating Cash Flow | 129.71 | 116.38 | 107.69 | 48.31 | 66.51 | 33.91 | Upgrade |
Operating Cash Flow Growth | 24.56% | 8.08% | 122.91% | -27.37% | 96.15% | 8.43% | Upgrade |
Capital Expenditures | -27.31 | -33.16 | -40.09 | -135.96 | -152.71 | -61.65 | Upgrade |
Sale of Property, Plant & Equipment | 0.03 | 0.03 | 0.03 | 0.06 | 0.01 | 0.1 | Upgrade |
Investment in Securities | -55.65 | 24.8 | -41.84 | 157.9 | -162.23 | -36.2 | Upgrade |
Other Investing Activities | 0 | - | - | -3.45 | - | 5.98 | Upgrade |
Investing Cash Flow | -82.93 | -8.33 | -81.9 | 18.55 | -314.93 | -91.77 | Upgrade |
Long-Term Debt Issued | - | - | - | - | 54.12 | 47.45 | Upgrade |
Long-Term Debt Repaid | - | -52.34 | -28.62 | -27.18 | -2.77 | - | Upgrade |
Net Debt Issued (Repaid) | -52.34 | -52.34 | -28.62 | -27.18 | 51.34 | 47.45 | Upgrade |
Issuance of Common Stock | 9.31 | 9.31 | - | - | 250.05 | - | Upgrade |
Repurchase of Common Stock | -11.51 | -11.51 | - | - | - | - | Upgrade |
Common Dividends Paid | -26.66 | -27.14 | -15.28 | -8.05 | - | - | Upgrade |
Other Financing Activities | 8.99 | - | - | - | -53.9 | -5.96 | Upgrade |
Financing Cash Flow | -72.2 | -81.67 | -43.9 | -35.23 | 247.49 | 41.49 | Upgrade |
Foreign Exchange Rate Adjustments | 0.34 | 0.16 | 0.02 | 2.97 | -0.42 | -0.33 | Upgrade |
Net Cash Flow | -25.09 | 26.54 | -18.09 | 34.61 | -1.35 | -16.7 | Upgrade |
Free Cash Flow | 102.39 | 83.22 | 67.6 | -87.65 | -86.2 | -27.74 | Upgrade |
Free Cash Flow Growth | 70.03% | 23.11% | - | - | - | - | Upgrade |
Free Cash Flow Margin | 34.72% | 29.89% | 29.28% | -44.89% | -56.05% | -22.46% | Upgrade |
Free Cash Flow Per Share | 1.55 | 1.27 | 1.02 | -1.32 | -1.52 | -0.56 | Upgrade |
Cash Income Tax Paid | 42.59 | 38.7 | 19.36 | 6.68 | 4.13 | 8.09 | Upgrade |
Levered Free Cash Flow | 46.97 | 28.34 | 17.89 | -118 | -127.14 | -26.65 | Upgrade |
Unlevered Free Cash Flow | 47.22 | 28.91 | 19.27 | -116.88 | -126.83 | -26.65 | Upgrade |
Change in Net Working Capital | 21.68 | 28.38 | -5.18 | 13.52 | 0.64 | -12.56 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.